⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Table S5 from Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

number samples with inferior limit of MRD

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Paiva et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523dd8 https://doi.org/10.1158/2643-3230.27024989

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S5 from Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel2024
2Table S3 from Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel2024
3Table S3 from Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel2024
4Table S2 from Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel2024
5Table S2 from Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel2024